193 related articles for article (PubMed ID: 6189039)
61. Combination chemotherapy and radiation therapy for small cell carcinoma.
Holoye PY; Samuels ML; Lanzotti VJ; Smith T; Barkley HT
JAMA; 1977 Mar; 237(12):1221-4. PubMed ID: 190427
[TBL] [Abstract][Full Text] [Related]
62. [A study of two protocols of multiple chemotherapy in small round cell tumours of the lung (author's transl)].
Israël L; Breau JL; Depierre A; Choffel C; Lemarié E; Battesti JP
Rev Fr Mal Respir; 1981; 9(2):123-31. PubMed ID: 6166970
[No Abstract] [Full Text] [Related]
63. Intensive induction therapy for small cell carcinoma of the lung.
Abeloff MD; Ettinger DS; Khouri NF; Lenhard RE
Cancer Treat Rep; 1979 Apr; 63(4):519-24. PubMed ID: 221117
[TBL] [Abstract][Full Text] [Related]
64. [Prevention of bronchopulmonary inflammation in patients with lung cancer receiving cytostatic therapy].
Viazitskiĭ PO; Iakovlev VN; Alekseev VG; Dmitriev IuK; Duganov VK
Klin Med (Mosk); 1988 Jun; 66(6):64-7. PubMed ID: 2460668
[No Abstract] [Full Text] [Related]
65. Combination chemotherapy for small cell carcinoma of the lung: evaluation of four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine.
Ohnoshi T; Hiraki S; Nakata Y; Machida K; Fujii M; Nakata Y; Murakami N; Miyake K; Harada J; Ozawa S; Seto T; Tamura T; Kimura I
Acta Med Okayama; 1983 Apr; 37(2):147-53. PubMed ID: 6307001
[TBL] [Abstract][Full Text] [Related]
66. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
67. Etoposide after ACO treatment for small-cell bronchogenic carcinoma.
Essers U; Knechten H; Seelis R; Ammon J
Cancer Treat Rev; 1982 Jun; 9 Suppl():111-3. PubMed ID: 6290054
[No Abstract] [Full Text] [Related]
68. An evaluation of combination chemotherapy with procarbazine (NSC-77213) and 5-fluorouracil (NSC-19893) in advanced carcinoma of the lung.
Gottlieb JA; Serpick AA
Cancer Chemother Rep; 1970 Oct; 54(5):369-71. PubMed ID: 5514626
[No Abstract] [Full Text] [Related]
69. Bronchial artery infusion of mitomycin-C in advanced bronchogenic carcinoma.
Hellekant C; Svanberg L
Acta Radiol Oncol Radiat Phys Biol; 1978; 17(6):449-62. PubMed ID: 83780
[TBL] [Abstract][Full Text] [Related]
70. Clinical evaluation of procarbazine and fluorouracil in advanced lung cancer.
Pacilio G; Puzziello T
Bronches; 1971; 21(4):402. PubMed ID: 4340778
[No Abstract] [Full Text] [Related]
71. Extensive-stage small-cell bronchogenic carcinoma: intensive induction chemotherapy with high-dose cyclophosphamide plus high-dose etoposide.
Johnson DH; Wolff SN; Hainsworth JD; Porter LL; Grosh WW; Hande KR; Greco FA
J Clin Oncol; 1985 Feb; 3(2):170-5. PubMed ID: 2981981
[TBL] [Abstract][Full Text] [Related]
72. Four-drug combination chemotherapy in extensive non-small cell lung cancer: a Southwest Oncology Group Pilot Study.
Livingston RB; Mira J; O'Bryan RM
Cancer Treat Rep; 1981; 65(1-2):143-4. PubMed ID: 6164484
[No Abstract] [Full Text] [Related]
73. MACC (methotrexate, adriamycin, cyclophosphamide and CCNU) in advanced lung cancer.
Chahinian AP; Mandel EM; Holland JF; Jaffrey IS; Teirstein AS
Cancer; 1979 May; 43(5):1590-7. PubMed ID: 221093
[No Abstract] [Full Text] [Related]
74. Treatment of modified Stage II (T1 N1 M0, T2 N1 M0) non-small cell bronchogenic carcinoma. A combined modality approach.
Newman SB; DeMeester TR; Golomb HM; Hoffman PC; Little AG; Raghavan V
J Thorac Cardiovasc Surg; 1983 Aug; 86(2):180-5. PubMed ID: 6308356
[TBL] [Abstract][Full Text] [Related]
75. Benefits of polychemotherapy in advanced non-small-cell bronchogenic carcinoma.
Cormier Y; Bergeron D; La Forge J; Lavandier M; Fournier M; Chenard J; Desmeules M
Cancer; 1982 Sep; 50(5):845-9. PubMed ID: 7093924
[TBL] [Abstract][Full Text] [Related]
76. [Principle products used in chemotherapy. Administration methods].
Boillon C; Olivro A; Lemerle J
Soins; 1979 Aug 5-20; 24(15-16):51-9. PubMed ID: 90390
[No Abstract] [Full Text] [Related]
77. [Clinical study of two chemotherapeutic combinations in the treatment of small-cell bronchogenic carcinoma].
Dangubić V; Vukov N; Mrda V; Spasić D; Sikimić S; Popvić D; Perunović O; Bjelić R
Zb Vojnomed Akad; 1983; 25():40-4. PubMed ID: 6099941
[No Abstract] [Full Text] [Related]
78. [3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)].
Liesenfeld A; Havemann K; Gropp C; Seifert W; Thomas C; Drings P; Mahnke HG; Westerhausen M; Wellens W; Konrad RM
Onkologie; 1984 Jun; 7(3):145-51. PubMed ID: 6087231
[TBL] [Abstract][Full Text] [Related]
79. [Results of combined treatment of advanced squamous cell carcinoma of the lung with vincristine, adriamycin and cyclophosphamide].
Krawczyk K; Krochmal M; Pawlicki M; Kulpa J; Zielezińska A
Pneumonol Pol; 1983 Feb; 51(2):107-11. PubMed ID: 6878054
[No Abstract] [Full Text] [Related]
80. [Adriamycin, cyclophosphamide and vincristine (ACO) in small cell bronchial cancer. Course of the disease and long-term follow-up].
Seeber S; Niederle N; Schilcher RB; Schmidt CG
Onkologie; 1980 Feb; 3(1):5-11. PubMed ID: 6258116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
